Mitsubishi UFJ Asset Management Co. Ltd. Increases Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 20.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 212,047 shares of the company's stock after purchasing an additional 35,471 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned 0.17% of Henry Schein worth $14,650,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Smartleaf Asset Management LLC grew its position in shares of Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after buying an additional 143 shares during the period. CIBC Asset Management Inc grew its holdings in Henry Schein by 1.0% during the 4th quarter. CIBC Asset Management Inc now owns 17,849 shares of the company's stock worth $1,235,000 after acquiring an additional 169 shares during the period. Metis Global Partners LLC raised its position in shares of Henry Schein by 4.7% during the 4th quarter. Metis Global Partners LLC now owns 4,203 shares of the company's stock valued at $291,000 after acquiring an additional 187 shares during the last quarter. Central Pacific Bank Trust Division boosted its position in shares of Henry Schein by 2.0% in the 4th quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company's stock worth $706,000 after purchasing an additional 200 shares during the last quarter. Finally, Sanctuary Advisors LLC boosted its stake in Henry Schein by 5.0% in the 4th quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company's stock worth $294,000 after purchasing an additional 203 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Price Performance

Shares of NASDAQ HSIC traded down $1.12 during trading hours on Friday, reaching $65.47. 2,362,489 shares of the stock traded hands, compared to its average volume of 1,585,938. The company's 50-day simple moving average is $73.96 and its two-hundred day simple moving average is $72.58. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 52-week low of $63.00 and a 52-week high of $82.49. The company has a market capitalization of $8.13 billion, a P/E ratio of 26.94, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the previous year, the firm posted $0.66 EPS. The company's revenue for the quarter was up 5.8% on a year-over-year basis. Equities research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Ratings Changes

Several research firms have issued reports on HSIC. Barrington Research reissued an "outperform" rating and issued a $90.00 price target on shares of Henry Schein in a research note on Wednesday, February 26th. UBS Group decreased their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and upped their target price for the company from $69.00 to $84.00 in a report on Monday, January 6th. Wells Fargo & Company began coverage on Henry Schein in a research report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price objective for the company. Finally, Jefferies Financial Group boosted their target price on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $81.10.

Insider Buying and Selling

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now directly owns 24,805 shares of the company's stock, valued at $1,762,147.20. This trade represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.